Risk of stroke in patients with idiopathic Parkinson disease

Parkinsonism and Related Disorders

Volumn 16, Issue 1, 2010, Pages 31-35

  Becker, Claudia ^a   Jick, Susan S ^b   Meier, Christoph R ^a,b  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b BOSTON UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Epidemiology; Parkinson disease; Stroke

Indexed keywords

LEVODOPA;

ADULT; AGED; ARTICLE; BRAIN HEMORRHAGE; CASE CONTROL STUDY; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; FEMALE; HIGH RISK PATIENT; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PARKINSON DISEASE; PREVALENCE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RISK ASSESSMENT; RISK FACTOR; STROKE; TRANSIENT ISCHEMIC ATTACK; UNITED KINGDOM;

ADULT; AGED; AGED, 80 AND OVER; COHORT STUDIES; CONFIDENCE INTERVALS; DATABASES, FACTUAL; FEMALE; GREAT BRITAIN; HUMANS; ISCHEMIC ATTACK, TRANSIENT; MALE; MIDDLE AGED; ODDS RATIO; PARKINSON DISEASE; RETROSPECTIVE STUDIES; RISK FACTORS; STROKE;

EID: 74149090924     PISSN: 13538020     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2009.06.005     Document Type: Article

References (30)

1. Zhu Y., Hoell P., Ahlemeyer B., Sure U., Bertalanffy H., and Kriegelstein J. Implication of PTEN in production of reactive oxygen species and neuronal death in in vitro models of stroke and Parkinson's disease. Neurochem Int 50 (2007) 507-516
2. Abou-Sleiman P.M., Healy D.G., and Wood N.W. Causes of Parkinson's disease: genetics of DJ-1. Cell Tissue Res 318 (2004) 185-188
3. Aleyasin H., Rousseaux M.W., Phillips M., Kim R.H., Bland R.J., Callaghan S., et al. The Parkinson's disease gene DJ-1 is also a key regulator of stroke-induced damage. Proc Natl Acad Sci USA 104 (2007) 18748-18753
4. Nataraj A., and Rajput A.H. Parkinson's disease, stroke, and related epidemiology. Mov Disord 20 (2005) 1476-1480
5. Levine R.L., Jones J.C., and Bee N. Stroke and Parkinson's disease. Stroke 23 (1992) 839-842
6. Struck L.K., Rodnitzky R.L., and Dobson J.K. Stroke and its modification in Parkinson's disease. Stroke 21 (1990) 1395-1399
7. Wood L., and Martinez C. The general practice research database: role in pharmacovigilance. Drug Saf 27 (2004) 871-881
8. Jick H. A database worth saving. Lancet 350 (1997) 1045-1046
9. Jick S.S., Kaye J.A., Vasilakis-Scaramozza C., Garcia Rodriguez L.A., Ruigomez A., Meier C.R., et al. Validity of the general practice research database. Pharmacotherapy 23 (2003) 686-689
10. Walley T., and Mantgani A. The UK general practice research database. Lancet 350 (1997) 1097-1099
11. Schade R., Andersohn F., Suissa S., Haverkamp W., and Garbe E. Dopamine agonists and the risk of cardiac-valve regurgitation. N Engl J Med 356 (2007) 29-38
12. Hernan M.A., Takkouche B., Caamano-Isorna F., and Gestal-Otero J.J. A meta-analysis of coffee drinking, cigarette smoking, and the risk of Parkinson's disease. Ann Neurol 52 (2002) 276-284
13. Hernan M.A., Logroscino G., and Rodriguez L.A. A prospective study of alcoholism and the risk of Parkinson's disease. J Neurol 251 Suppl. 7 (2004) VII14-7
14. Hernan M.A., Logroscino G., and Garcia Rodriguez L.A. Nonsteroidal anti-inflammatory drugs and the incidence of Parkinson disease. Neurology 66 (2006) 1097-1099
15. Alonso A., Rodriguez L.A., Logroscino G., and Hernan M.A. Gout an risk of Parkinson disease: a prospective study. Neurology 69 (2007) 1696-1700
16. Rector I., Rectorova I., and Kubova D. Vascular parkinsonism - an update. J Neurol Sci 248 (2006) 185-191
17. Mastaglia F.L., Johnsen R.D., and Kakulas B.A. Prevalence of stroke in Parkinson's disease: a postmortem study. Mov Disord 17 (2002) 772-774
18. Jellinger K.A. Prevalence of stroke in Parkinson's disease. Mov Disord 18 (2003) 723-724
19. Korten A., Lodder J., Vreeling F., Boreas A., van Raak L., and Kessels F. Stroke and idiopathic Parkinson's disease: does a shortage of dopamine offer protection against stroke?. Mov Disord 16 (2001) 119-123
20. Kessler I. Epidemiologic studies in Parkinson's disease. II A hospital-based survey. Am J Epidemiol 96 (1972) 242-254
21. Marttila R.J., and Rinne U.K. Arteriosclerosis, heredity, and some previous infections in the etiology of Parkinson's disease. A case-control study. Clin Neurol Neurosurg 79 (1976) 46-56
22. Shinton R., and Beevers G. Meta-analysis of relation between cigarette smoking and stroke. BMJ 298 (1989) 789-794
23. Postuma R.B., and Lang A.E. Homocysteine and levodopa. Neurology 63 (2004) 886-891
24. Rogers J.D., Sanchez-Saffon A., Frol A.B., and Diaz-Arrastia R. Elevated plasma homocysteine levels in patients treated with levodopa. Arch Neurol 60 (2003) 59-64
25. Scigliano G., Ronchetti G., Girotti F., and Musicco M. Levodopa reduces risk factors for vascular disease in parkinsonian patients. J Neurol 255 (2008) 1266-1267
26. Hughes A.J., Daniel S.E., Kilford L., and Lees A.J. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55 (1992) 181-184
27. de Rijk M.C., Tzourio C., Breteler M.M., Dartigues J.F., Amaducci L., Lopez-Pousa S., et al. Prevalence of parkinsonism and Parkinson's disease in Europe: the EUROPARKINSON Collaborative Study. European community concerted action on the epidemiology of Parkinson's disease. J Neurol Neurosurg Psychiatry 62 (1997) 10-15
28. Schrag A., Ben-Shlomo Y., and Quinn N. How valid is the clinical diagnosis of Parkinson's disease in the community?. J Neurol Neurosurg Psychiatry 73 (2002) 529-534
29. Rajput A.H., Rozdilsky B., and Rajput A. Accuracy of clinical diagnosis in parkinsonism - a prospective study. Can J Neurol Sci 18 (1991) 275-278
30. Caslake R., Moore J.N., Gordon J.C., Harris C.E., and Counsell C. Changes in diagnosis with follow-up in an incident cohort of patients with parkinsonism. J Neurol Neurosurg Psychiatry 79 (2008) 1202-1207